Efficacy and safety of a fixed combination of insulin degludec/insulin aspart in children and adolescents with type 1 diabetes: A randomized trial.
Tadej BattelinoLarry C DeebMagnus EkelundOna KinduryteGeorgeanna J KlingensmithMirjana KocovaMargarita KovarenkoNaim ShehadehPublished in: Pediatric diabetes (2018)
IDegAsp + IAsp was non-inferior to IDet + IAsp regarding HbA1c, had similar hypoglycemia rates and required fewer injections.